Cristina Saavedra

499 total citations
36 papers, 249 citations indexed

About

Cristina Saavedra is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cognitive Neuroscience. According to data from OpenAlex, Cristina Saavedra has authored 36 papers receiving a total of 249 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 5 papers in Cognitive Neuroscience. Recurrent topics in Cristina Saavedra's work include HER2/EGFR in Cancer Research (7 papers), Advanced Breast Cancer Therapies (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Cristina Saavedra is often cited by papers focused on HER2/EGFR in Cancer Research (7 papers), Advanced Breast Cancer Therapies (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Cristina Saavedra collaborates with scholars based in Spain, Switzerland and United Kingdom. Cristina Saavedra's co-authors include Jaime Iglesias, Ela I. Olivares, Nelson J. Trujillo‐Barreto, Mitchell Valdés-Sosa, Ainara Soria, Pablo Gajate, Cristian Perna, Teresa Alonso Gordoa, Víctor Albarrán and Diana Isabel Rosero and has published in prestigious journals such as Cancer, Scientific Reports and Annals of Oncology.

In The Last Decade

Cristina Saavedra

33 papers receiving 246 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cristina Saavedra Spain 8 104 97 57 32 19 36 249
Michael D. Kuo United States 11 36 0.3× 42 0.4× 86 1.5× 11 0.3× 14 0.7× 29 303
David A. Gonzalez Canada 10 62 0.6× 105 1.1× 90 1.6× 16 0.5× 24 1.3× 17 316
Edwin Peguero United States 8 50 0.5× 36 0.4× 43 0.8× 5 0.2× 12 0.6× 25 254
Rebecca A. Marks United States 12 38 0.4× 123 1.3× 101 1.8× 12 0.4× 6 0.3× 32 368
Stefano Bravi Italy 6 47 0.5× 69 0.7× 91 1.6× 29 0.9× 25 1.3× 14 246
Isabel Fernández-Navarro Spain 8 27 0.3× 37 0.4× 94 1.6× 35 1.1× 11 0.6× 9 295
Matthias Mäurer Germany 8 43 0.4× 61 0.6× 23 0.4× 19 0.6× 6 0.3× 27 216
Xu‐Lin Liao China 8 22 0.2× 45 0.5× 20 0.4× 7 0.2× 23 1.2× 38 250
Zhigang Zhang China 11 118 1.1× 21 0.2× 115 2.0× 7 0.2× 11 0.6× 24 346
Jennifer Park United States 9 31 0.3× 32 0.3× 22 0.4× 15 0.5× 56 2.9× 18 293

Countries citing papers authored by Cristina Saavedra

Since Specialization
Citations

This map shows the geographic impact of Cristina Saavedra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cristina Saavedra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cristina Saavedra more than expected).

Fields of papers citing papers by Cristina Saavedra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cristina Saavedra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cristina Saavedra. The network helps show where Cristina Saavedra may publish in the future.

Co-authorship network of co-authors of Cristina Saavedra

This figure shows the co-authorship network connecting the top 25 collaborators of Cristina Saavedra. A scholar is included among the top collaborators of Cristina Saavedra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cristina Saavedra. Cristina Saavedra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marhold, Maximilian, Marta Vaz Batista, Isabel Blancas, et al.. (2025). TUXEDO-4: phase II study of trastuzumab-deruxtecan in HER2-low breast cancer with new or progressing brain metastases. Future Oncology. 21(9). 1065–1073. 2 indexed citations
2.
3.
Gorospe, Luis, Cristina Saavedra, & Noelia Martínez-Jáñez. (2025). Eribulin-induced pulmonary toxicity mimicking metastatic lung disease. Medicina Clínica. 165(1). 106993–106993.
4.
Cruz, Víctor L., Laura García‐Estévez, José Manuel Pérez-García, et al.. (2025). In silico decrypting of the bystander effect in antibody–drug conjugates for breast cancer therapy. Scientific Reports. 15(1). 28715–28715.
5.
Caballol, Berta, Cristina Saavedra, A Fernández-Clotet, et al.. (2024). P276 Predictive value of changes in 3D volumetry in perianal fistulas in patients with Crohn’s disease under biologic therapy. A pilot study. Journal of Crohn s and Colitis. 18(Supplement_1). i636–i636. 2 indexed citations
6.
7.
8.
Saavedra, Cristina, María Gión, Javier Cortés, & Antonio Llombart‐Cussac. (2023). Top advances of the year: Breast cancer. Cancer. 129(12). 1791–1794. 3 indexed citations
9.
Gampenrieder, Simon Peter, Vincent O. Dezentjé, Matteo Lambertini, et al.. (2022). 177P Low HER2 expression does not influence prognosis in metastatic triple-negative breast cancer: Results from an international, multicenter analysis coordinated by the Austrian Group Medical Tumor Therapy (AGMT). Annals of Oncology. 33. S208–S208. 3 indexed citations
10.
Albarrán, Víctor, Jesús Chamorro, Diana Isabel Rosero, et al.. (2022). Neurologic Toxicity of Immune Checkpoint Inhibitors: A Review of Literature. Frontiers in Pharmacology. 13. 774170–774170. 36 indexed citations
11.
Saavedra, Cristina, et al.. (2020). Impact of Covid-19 in Cancer Patients Treated with Immunotherapy: A Review. Journal of Clinical Toxicology. 10(5). 1–4. 1 indexed citations
12.
Saavedra, Cristina, et al.. (2020). Myocarditis and carotidynia caused by Granulocyte-Colony stimulating factor administration. Modern Rheumatology Case Reports. 4(2). 318–323. 5 indexed citations
13.
Saavedra, Cristina, et al.. (2019). <p>Cardiac toxicity of immune-checkpoint inhibitors: a clinical case of nivolumab-induced myocarditis and review of the evidence and new challenges</p>. Cancer Management and Research. Volume 11. 4541–4548. 24 indexed citations
14.
Ocaña, Juan, et al.. (2019). Relevancia del margen de resección positivo en adenocarcinoma ductal de páncreas y otros factores pronósticos. Cirugía Española. 98(2). 85–91. 4 indexed citations
15.
Saavedra, Cristina, Ángela Lamarca, & Richard Hubner. (2019). Resolution of necrolytic migratory erythema with somatostatin analogue in a patient diagnosed with pancreatic glucagonoma. BMJ Case Reports. 12(8). e229115–e229115. 3 indexed citations
16.
Saavedra, Cristina, Ela I. Olivares, & Jaime Iglesias. (2012). Cognitive decline effects at an early stage: Evidence from N170 and VPP. Neuroscience Letters. 518(2). 149–153. 13 indexed citations
17.
Saavedra, Cristina, Jaime Iglesias, & Ela I. Olivares. (2012). Event-Related Potentials Elicited By Face Identity Processing In Elderly Adults With Cognitive Impairment. Experimental Aging Research. 38(2). 220–245. 20 indexed citations
18.
Saavedra, Cristina. (2011). Envejecimiento y demencias. 24–25. 6 indexed citations
19.
Saavedra, Cristina, et al.. (2010). Event-Related Potentials Elicited by the Explicit and Implicit Processing of Familiarity in Faces. Clinical EEG and Neuroscience. 41(1). 24–31. 15 indexed citations
20.
Saavedra, Cristina. (2006). El Informe Kinsey. 20–22. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael D. Kuo Breakdown of academic impact, for papers by David A. Gonzalez Breakdown of academic impact, for papers by Edwin Peguero Breakdown of academic impact, for papers by Rebecca A. Marks Breakdown of academic impact, for papers by Stefano Bravi Breakdown of academic impact, for papers by Isabel Fernández-Navarro Breakdown of academic impact, for papers by Matthias Mäurer Breakdown of academic impact, for papers by Xu‐Lin Liao Breakdown of academic impact, for papers by Zhigang Zhang Breakdown of academic impact, for papers by Jennifer Park
Rankless by CCL
2026